Empagliflozin, an SGLT2 inhibitor, is proven safe and effective for heart attack patients, offering a new treatment option to improve outcomes.

In patients hospitalized for medlinkacute myocardial infarction/medlink (MI), the SGLT2 inhibitor empagliflozin offers significant kidney...

Nearly 500 million adults worldwide are living with type 2 diabetes, and over 200 million of them take metformin, a common medication that helps lower...

Scientists from Western University have discovered a promising molecule found in sweet oranges and tangerines called nobiletin, which may help combat...

When not addressed, the prolonged chronic high blood sugar levels may lead to damaged body systems. This damage is particularly problematic for the...

A recent study from the University of Toronto has found that eating nuts instead of carbohydrates may help people with type 2 diabetes manage their...

Researchers from the University of Missouri have found that an FDA-approved drug used to lower blood sugar in adults with type 2 diabetes may also...

Researchers have discovered that a simple blood test can predict a woman’s risk of heart disease up to 30 years in advance. By measuring two types...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...

Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...